Risk Factors for Acute Kidney Injury in Adult Patients Receiving Vancomycin

被引:0
作者
Diane Cappelletty
Alyse Jablonski
Rose Jung
机构
[1] The University of Toledo,College of Pharmacy and Pharmaceutical Sciences
[2] Omnicare,undefined
来源
Clinical Drug Investigation | 2014年 / 34卷
关键词
Chronic Kidney Disease; Vancomycin; Trough Concentration; Vancomycin Therapy; Serum Trough Concentration;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:189 / 193
页数:4
相关论文
共 48 条
[1]  
Griffith RS(1981)Introduction to vancomycin Rev Infect Dis 3 S200-416
[2]  
Rybak MJ(2005)Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia Am J Respir Crit Care Med 171 388-327
[3]  
Lomaestro BM(2009)Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists Clin Infect Dis 49 325-475
[4]  
Rotschafer JC(1990)Nonsteroidal anti-inflammatory drug-associated azotemia in the very old JAMA 264 471-598
[5]  
Gurwitz JH(1991)Nonsteroidal anti-inflammatory drugs: effects on kidney function J Clin Pharmacol 31 588-27S
[6]  
Avorn J(2013)Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study BMJ 346 e8525-850
[7]  
Ros-Degnan D(2001)Epidemiologic assessment of the safety of conventional nonsteroidal anti-inflammatory drugs Am J Med 110 20S-55
[8]  
Whelton A(2004)Predictors of new-onset kidney disease in a community-based population JAMA 291 844-1129
[9]  
Hamilton C(2003)Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community J Am Coll Cardiol 41 47-1283
[10]  
Lapi F(2003)Level of kidney function as a risk factor for cardiovascular outcomes in the elderly Kidney Int 63 1121-290